Food and Drug Administration

Why artificial intelligence will never replace your job

Artificial Intelligence people keep reassuring everyone else their jobs are safe. What is it about AI that makes people think it could possibly replace them?

Tom Temin Commentary

Senate takes big step to avoid government shutdown

Federal Newscast

Real-time feedback is central to FDA’s upcoming goals for customer experience

Technology

The FDA ponders whether artificial intelligence can help with drug approval

Artificial Intelligence

CX Exchange 2023: FDA’s Josh Lehman on how his agency’s not so different from Zappos — employees come first

Technology

FILE - A sign for the Food and Drug Administration is seen in Silver Spring, Md., on Thursday, Dec. 10, 2020. On Wednesday, March 30, 2022, federal health advisers narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig’s disease, a potential setback for patient groups who lobbied for the medication’s approval. A majority of advisers to the FDA voted 6-4 that a single study from Amylyx Pharmaceuticals failed to establish the drug's effectiveness in treating the deadly neurodegenerative disease known also as ALS, for amyotrophic lateral sclerosis. (AP Photo/Manuel Balce Ceneta)

FDA is told to tighten up its procedures for IT procurement

Management

FDA looks to keep tabs on ‘common efforts’ to improve public health through master data management

Federal Insights

FILE - Traders work on the floor at the New York Stock Exchange in New York, Aug. 10, 2022. Stocks teetered between small gains and losses in morning trading on Wall Street Thursday, Sept. 15, 2022 which left major indexes well in the red for the week. (AP Photo/Seth Wenig, File)

Are senior federal employees violating ethics rules en masse?

Agency Oversight

Sunlight shines on the U.S. Capitol Dome in Washington, Friday, Jan. 7, 2022. (AP Photo/Patrick Semansky)

Biden signs continuing resolution into law averting government shutdown, FDA furloughs

Budget

FILE - This Aug. 2, 2018 file photo shows the U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md. The Food and Drug Administration has issued a negative review of a closely watched experimental drug for the debilitating illness known as Lou Gehrig’s disease. The review comes ahead of a meeting this week for outside experts to vote on the drug for ALS. The drug has been the focal point of a lobbying campaign by patients, their families and lawmakers. FDA reviewers said Monday, March 28, 2022 the single study from Amylyx Pharmaceuticals was “not persuasive” due to missing data, errors in enrolling patients and other problems. (AP Photo/Jacquelyn Martin, File)

Deadline approaches to pass bill affecting employment for 3,500 FDA workers

Congress

Veterans Affairs is looking at treating some mental health problems with psychedelics

Veterans Affairs

USDA’s new answer to cutting food waste by 50%: Jelly ice

An investment from the USDA’s National Institute of Food and Agriculture (NIFA) is paving the way for a new type of ice cube to revolutionize how industries…

Technology

This FDA lawyer was instrumental in limits on cigarette marketing

Since the FDA got authority from Congress in 2009 to regulate tobacco marketing, smoking rates in the United States have dropped to 10% for adults and…

People

This FDA scientist’s work helps public health officials find sources of tainted food faster

People

Steven Musser, deputy director for Scientific Operations in the FDA’s Center for Food Safety and Applied Nutrition, developed the application of a methodology called genomic epidemiology.